Pfizer Opioid Marketing Agreement With Chicago Follows Help In Suit Against Other Firms
This article was originally published in The Pink Sheet Daily
Pfizer will disclose opioid risks in its promotional activities and will help with public education and disposal efforts; company has provided evidence to Chicago in its litigation against five other opioid manufacturers.
You may also be interested in...
Company is paying nearly $200m for an Oklahoma State University endowment, $12.5m to abate effects of opioid crisis and $60m for litigation costs.
Off-label marketing and kickbacks may no longer be the top targets of government healthcare fraud investigations as more companies are being hit with subpoenas for pricing information.
Boston jury clears Carl Reichel of conspiring to pay kickbacks to physicians in case involving dinners and speaker fees.